Search
for
Sort by
Research 31–60 of 43
- Pharmacophore and Atom Based 3D QSAR Studies on the Novel 5-Alpha-Reductase Inhibitors
- Analysis of Data From Breast Diseases Treated With 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia
- Exploring the Potential of Eclipta alba: A Promising Approach for Hair Treatment Management through 5-Alpha Reductase Inhibition
- The utilisation of cardiac risk ratio and non-HDL cholesterol markers to assess cardiovascular risk in type 2 diabetes males with lowered serum DHT
- Hair growth and rejuvenation: An overview
- Oral administration of low-dose bisphenol A promotes proliferation of ventral prostate and upregulates prostaglandin D<sub>2</sub> synthase expression in adult rats
- Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia
- Discovery of Natural Steroid 5 Alpha-Reductase Inhibitors
- 5 Alpha-Reductase Inhibitory Potential of Solanum nigrum Effective for Management of Alopecia
- Ent-kaurane-type diterpenoids from Isodonis Herba activate human hair follicle dermal papilla cells proliferation via the Akt/GSK-3β/β-catenin transduction pathway
- In silico structural prediction of human steroid 5α-reductase type II
- Extensive Challenges and Pending Advances in the Study of 5-Alpha-Reductase Isoenzymes. A Literature Review
- Determination of 19 illegally added chemical ingredients in hair loss prevention cosmetics by ultra-performance liquid chromatography-quadrupole-time of flight mass spectrometry
- Discovery of a novel hybrid from finasteride and epristeride as 5α-reductase inhibitor
- Effection of Epristeride and Finasteride on Spermatogenesis in Male Rats
- Analysis of metabolic characteristics of epristeride in zebrafish based on LC-Q-TOF MS and its potential applications in doping control
- Identification of Metabolites for the Novel 5α‐Reductase Inhibitor Epristeride In Vitro and Its Potential Impact on Doping Testing
- ChemInform Abstract: Discovery of a Novel Hybrid from Finasteride and Epristeride as 5α‐Reductase Inhibitor.
- An overview on 5α-reductase inhibitors
- Chapter 23. Therapeutic Control of Androgen Action
- 5α-Reductase Inhibitors Do Not Prevent the Development and Progression of Urothelial Cancer: In Vitro Evidence
- Market Analysis of 5α-Reductase Inhibitor
- Screen steroid 5 alpha-reductase inhibitors in vitro by high performance liquid chromatography
- New Synthesis of Methyl 3β-Hydroxy-5-androstene-17β-carboxylate
- Design, synthesis and biological evaluation of novel androst-3,5-diene-3-carboxylic acid derivatives as inhibitors of 5α-reductase type 1 and 2
- FCE 28260, a new 5α-reductase inhibitor: In vitro and in vivo effects
- Synthesis and in vitro study of 17β-[N-ureylene-N,N′-disubstituted]-4-methyl-4-aza-5α-androstan-3-ones as selective inhibitors of type I 5α-reductase
- Cutaneous Androgen Metabolism: Basic Research and Clinical Perspectives
- The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human Diseases
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases